FDA approves test for right treatment of hepatitis C

Windsor Genova – Fourth Estate Cooperative Contributor

Washington, DC, United States (4E) – The Food and Drug Administration (FDA) approved on Wednesday a medical test t

The genotypes are 1, 1a, 1b, 2, 3, 4, and 5. Each type has a corresponding treatment different from the other types. The 1a and 1b types are hardest to treat, according to University of Tennessee Health Science Center professor Tony Marion.

The test called Abbott RealTime HCV Genotype II identifies the genotype of the hepatitis C virus in an infected person’s blood.

The benefits of a right treatment are reduced cost of drug therapy and lesser side effects.

The Abbott RealTime HCV Genotype II test gives hope to some 3.2 million Americans suffering from the blood-borne disease. An estimated 15,000 Americans die from hepatitis C every year.

Hepatitis C sufferers seldom notice symptoms leading to chronic infection, liver cancer, severe liver damage and liver failure. The disease is also the leading cause of liver transplants in the U.S. , according to the Centers for Disease Control and Prevention.

Article © AHN – All Rights Reserved
About the Author

Leave a Reply